Molecular marker identifies normal stem cells as intestinal tu...( Scientists at St. Jude Children's Re...),Health
Navigation Links
Molecular marker identifies normal stem cells as intestinal tumor source
Date:12/17/2008
Scientists at St. Jude Children's Research Hospital have answered a central question in cancer biology: whether normal stem cells can give rise to tumors. Stem cells are immature cells that can renew themselves and give rise to mature differentiated cells that compose the range of body tissues. In recent years, researchers have developed evidence that cancers may arise from mutant forms of stem cells.
Like a brand-name product instantly identifiable by its trademarked logo, normal and cancerous stem cells display on their surface characteristic proteins, including Prominin1 or CD133. A key question in cancer biology has been whether these so-called cancer stem cells arise from normal stem cells or more mature cancer cells that somehow reacquire the characteristics of stem cells.
In the advanced, online issue of the journal Nature, St. Jude investigators show that Prominin1 marks normal intestinal stem cells and that these cells, when mutated, give rise to intestinal tumors. The finding could also aid in identifying the source of cancer stem cells in the lung, kidney, brain, pancreas and other tissues.
"The idea that cancers might arise from mutant stem cells is an attractive one; but until now the link between normal and cancer stem cells in solid tissues like the intestine was not known," said Richard Gilbertson, M.D., Ph.D., associate member of the St. Jude Developmental Neurobiology and Oncology departments and the paper's senior author. "Our work provides the first direct link between normal solid tissue stem cells and cancer. The fact that this occurs in the intestine is particularly interesting since human intestinal tumors contain Prominin1-expressing cancer stem cells."
In addition to providing insights into the origins of cancer, the work might help scientists identify more effective treatments. "Normal stem cells are designed to withstand environmental insults," Gilbertson said. "Thus cancer stem cells mi
'/>"/>
| Contact: Carrie Strehlau media@stjude.org 901-595-2295 St. Jude Children's Research Hospital Source:Eurekalert |
Related medicine news :
1. A new molecular zip code, and a new drug target for Huntingtons disease
2. New knock-out gene model provides molecular clues to breast cancer
3. Molecular probe paints cancer cells in living animals, Stanford researchers find
4. Story ideas from molecular & cellular proteomics
5. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
6. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
7. Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
8. Molecular profiling can accurately predict survival in colon cancer patients
9. Xceed Molecular Names Fran Tuttle to Its Board of Trustees
10. Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative
11. Xceed Molecular Launches Ziplex(R) Automated Gene-Expression System at the Association for Molecular Pathology, Booth 84/85
Post Your Comments:
(Date:11/30/2009)...ease Control and Prevention estimate that well ove...cted with HIV/AIDS. New research from North Caroli...ted are minorities and do not have health insuranc... to facilitate education and prevention efforts in...arch, which analyzed 90,000 HIV patient hospital v...
(Date:11/30/2009)...Author of "My Two-Year Old Eats Octopus,"...e to eat everything. , (P...er in your house? Do you find yourself acting as ...nline videos – one focusing on packing lunch...wers for real-life parents’ questions &ndash...
(Date:11/30/2009)..., Colo., Nov. 30 Baxa Corporation ...ng what "culture of safety" means in today,s pharm...n, "Creating a Culture of Safety in Pharmacy ," f...cussing their experiences with culture of safety, ...macy and the role of technology in enabling or inh...
(Date:11/30/2009)...h., Nov. 30 Stryker Corp...e agreement to acquire privately held Ascent Heal...processing and remanufacturing of medical devices ...t, Stryker will acquire Ascent Healthcare Solution... closing is conditioned on the expiration or termi...
(Date:11/30/2009)...d treating a tumor without disturbing normal tissu...e therapies can be invasive and harsh. , Researc...d a way they might deliver the right therapy direc...mers, which specifically bind to living tumor tiss...a rodent with liver cancer until they found the be...
Breaking Medicine News(10 mins):Health News:Research highlights need for national HIV strategy 2Health News:New Videos Help Parents of Picky Eaters 2Health News:New Videos Help Parents of Picky Eaters 3Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 3Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 2Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 3Health News:First live targeting of tumors with RNA-based technology 2Health News:First live targeting of tumors with RNA-based technology 3[0] Research highlights need for national HIV strategy[0] New Videos Help Parents of Picky Eaters[0] Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned[0] Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions[0] First live targeting of tumors with RNA-based technology
...er Orthopedic Group, Inc. announced today that Vin...e Vice President and Chief Growth Officer, effecti... Chief Executive Officer Thomas F. Kirk, Asar will...ching new businesses consistent with the company,s...
...d Corporation (Rite Aid) and nine of its subsidiar...in civil penalties to settle allegations of violat...epartment of Justice announced today. , , In add...to ensure compliance with all requirements of the ...
...ide relief from neuropathic pain , The pain that...ed by the trauma of amputation, entrapment, and co... extremely debilitating, and treatments show limit...ibutors to the pain. However, Halina Machelska and...
...immer Holdings, Inc.,(NYSE: ZMH ; SWX: ZMH) anno...p;T,Corporation executive, has been appointed to i... serves on the boards of three other publicly trad...y regulated,markets," said John L. McGoldrick, Cha...
...Unite Americans in Fighting the Country,s Most Com...s Foundation today announces the launch of Let,s ...mprove the quality of life of the one-in-five Amer...s Move Together is designed to inspire people to ...
...eotaxis, Inc.,(Nasdaq: STXS ) today announced th...g the RF PowerAssert(TM) Magnetic Guidewire. Clea...08, the RF PowerAssert guidewire is the only,magne...ve solution that enables precise intra-lesion cont...
Other Medicine News:Health News:Hanger Orthopedic Group Welcomes Vinit Asar as Chief Growth Officer 2Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 2Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 3Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 4Health News:JCI online early table of contents: Jan. 12, 2009 2Health News:JCI online early table of contents: Jan. 12, 2009 3Health News:JCI online early table of contents: Jan. 12, 2009 4Health News:JCI online early table of contents: Jan. 12, 2009 5Health News:Zimmer Holdings Names Betsy Bernard to Board of Directors 2Health News:Zimmer Holdings Names Betsy Bernard to Board of Directors 3Health News:Photos: Arthritis Foundation Launches Nationwide Movement Encouraging People to Move to Prevent and Treat Arthritis 2Health News:Photos: Arthritis Foundation Launches Nationwide Movement Encouraging People to Move to Prevent and Treat Arthritis 3Health News:Stereotaxis Annouces First CTO Crossing Procedure With RF PowerAssert(TM) Magnetic Guidewire 2Health News:Stereotaxis Annouces First CTO Crossing Procedure With RF PowerAssert(TM) Magnetic Guidewire 3Hanger Orthopedic Group Welcomes Vinit Asar as Chief Growth OfficerRite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances ActJCI online early table of contents: Jan. 12, 2009Zimmer Holdings Names Betsy Bernard to Board of DirectorsPhotos: Arthritis Foundation Launches Nationwide Movement Encouraging People to Move to Prevent and Treat ArthritisStereotaxis Annouces First CTO Crossing Procedure With RF PowerAssert(TM) Magnetic Guidewire
(Date:11/30/2009)..., , KING OF PRUSSIA, Pa., Nov. 30 /PRNewswi...ed the completion of a Phase I study of CPSI-2364,...e production of TNF-alpha and other pro-inflammato...ity dose escalation study in healthy volunteers co...cal testing. ,, All 30 enrolled subjects comp...
(Date:11/30/2009)..., , WALTHAM, Mass., Nov. 30 /PRNewswir..., the global authority on medical technology marke...ial injectable market declined by almost 5% over 2... as a result of the economic crisis. The market wi...will return to the strong pre-recession growth rat...
(Date:11/30/2009)..., , ATLANTA, Nov. 30 Amoe...urgery breast care products, is sponsoring the 4th...or the first time, Amoena will honor survivors and... by awarding a cabin for the one with the most ins...test, Amoena wants to hear about young mothers who...
Breaking Medicine Technology:Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Amoena and Young Survival Coalition Celebrate Breast Cancer Survivors With Contest and Cruise 2TGen led team is 1 of 7 selected for 241 million skin cancer grants 53469 1TGen led team is 1 of 7 selected for 241 million skin cancer grants 53469 2TGen led team is 1 of 7 selected for 241 million skin cancer grants 53469 3TGen led team is 1 of 7 selected for 241 million skin cancer grants 53469 4Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Low 53464 1Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Low 53464 2Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Low 53464 3URL Pharma Acquires PharmPro Manufacturing Facility and Equipment 53460 1URL Pharma Acquires PharmPro Manufacturing Facility and Equipment 53460 2...nte Carlo brings predictability to whole range ...s, WAYLAND, Mass., Sept. 4 Tourtellotte Solution...ply chain software for the,biopharmaceutical, reta...,the release of its tcVisualize(TM) 3.0 clinical t...ualize software now offers wide support for variab...
...itional very late stent thrombosis, NATICK, Mass....orporation (NYSE: BSX ) today announced five-year...l, demonstrating continued,long-term safety and ef...ystem. Among the findings, the TAXUS stent showed ...and five, while the bare-metal control,experienced...
Other Medicine Technology:Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator 2Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent 2Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent 3Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent 4| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |